Wision A.I. Expands U.S. Offerings to Combat Colorectal Cancer With Multiple Screening Tools

Wision A.I. Ltd. has announced the expansion of its product portfolio with recent U.S. FDA 510(k) Clearance for EndoScreener, its … continue reading “Wision A.I. Expands U.S. Offerings to Combat Colorectal Cancer With Multiple Screening Tools”